Lanadelumab in Participants Hospitalized With COVID-19 Pneumonia

Stopped Study was withdrawn due to challenges in site recruitment and lack of patient enrollment

Conditions

• COVID-19 Pneumonia

Interventions

• DRUG: Lanadelumab
• OTHER: Placebo

Sponsor

Shire

Collaborators

• [object Object]